The Committee is requesting actors in the health care sector to
submit "white papers" in PDF or Microsoft Word format
that address potential improvements in the following
Program Integrity Reforms to Protect Beneficiaries and Prevent
Fraud and Abuse
Payment Integrity Reforms to Ensure Accuracy, Efficiency and
Fraud and Abuse Enforcement Reforms to Ensure Tougher Penalties
Against Those Who Commit Fraud
The white papers should be submitted via email by June 29th to
The Committee members plan to have their staff review the white
papers and then compile a summary document highlighting key
proposals later in 2012.
This letter is the most recent instance where the government has
sought the expertise of the private sector in addressing fraud,
waste, and abuse. Another example came to light in February 2012,
when HHS-OIG issued its report related to the Pharmacy Compliance
Roundtable, where it convened compliance professionals in the
pharmaceutical industry. There, the private sector players
discussed their experiences with Corporate Integrity Agreements
(CIAs) and other compliance efforts initiated by the government
with HHS-OIG representatives. Prevention is becoming the new focus
of fraud-fighting efforts, and the government needs private sector
cooperation to achieve its goals in this area.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
A recently publicized settlement with the Office of Civil Rights of the U.S. Department of Health and Human Services highlights that it is not only important to have a HIPAA-compliant form of business associate agreement, but also to train staff to identify and carefully analyze when a BAA is required.
North Memorial Health Care of Minnesota ("North Memorial"), a comprehensive not-for-profit health care system, has agreed to pay $1.55 million to settle charges that it potentially violated the HIPAA Privacy and Security Rules.
We've thought a lot about the various secondary entities
that plaintiffs sometimes sue in prescription medical product
liability litigation – such as sales reps, physicians,
hospitals, pharmacies, distributors, and a number of others.
The US Department of Labor (DOL) has provided guidance on health plan provisions that could trigger a violation of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA), as amended by the Affordable Care Act.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).